Annual Accounts Payable
$6.06 M
-$8.12 M-57.25%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual accounts payable is $6.06 million, with the most recent change of -$8.12 million (-57.25%) on December 31, 2023.
- During the last 3 years, YMAB annual accounts payable has fallen by -$3.31 million (-35.34%).
- YMAB annual accounts payable is now -57.25% below its all-time high of $14.18 million, reached on December 31, 2022.
Performance
YMAB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.88 M
-$2.31 M-22.69%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly accounts payable is $7.88 million, with the most recent change of -$2.31 million (-22.69%) on September 30, 2024.
- Over the past year, YMAB quarterly accounts payable has increased by +$1.82 million (+30.00%).
- YMAB quarterly accounts payable is now -46.27% below its all-time high of $14.66 million, reached on March 31, 2022.
Performance
YMAB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
YMAB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.3% | +30.0% |
| 3 y3 years | -35.3% | -44.4% |
| 5 y5 years | +3.2% | -44.4% |
YMAB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | at low | -46.3% | +30.0% |
| 5 y | 5-year | -57.3% | at low | -46.3% | +30.0% |
| alltime | all time | -57.3% | +172.1% | -46.3% | +85.7% |
Y-mAbs Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.88 M(-22.7%) |
| Jun 2024 | - | $10.19 M(+51.5%) |
| Mar 2024 | - | $6.73 M(+11.0%) |
| Dec 2023 | $6.06 M(-57.2%) | $6.06 M(-20.4%) |
| Sep 2023 | - | $7.61 M(+4.9%) |
| Jun 2023 | - | $7.25 M(-18.0%) |
| Mar 2023 | - | $8.84 M(-37.6%) |
| Dec 2022 | $14.18 M(+4.6%) | $14.18 M(+3.3%) |
| Sep 2022 | - | $13.72 M(+21.5%) |
| Jun 2022 | - | $11.29 M(-23.0%) |
| Mar 2022 | - | $14.66 M(+8.2%) |
| Dec 2021 | $13.55 M | $13.55 M(+22.9%) |
| Sep 2021 | - | $11.02 M(+62.0%) |
| Jun 2021 | - | $6.80 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $6.54 M(-30.2%) |
| Dec 2020 | $9.37 M(+10.0%) | $9.37 M(-9.2%) |
| Sep 2020 | - | $10.32 M(+5.0%) |
| Jun 2020 | - | $9.82 M(-4.2%) |
| Mar 2020 | - | $10.26 M(+20.4%) |
| Dec 2019 | $8.52 M(+45.1%) | $8.52 M(+11.7%) |
| Sep 2019 | - | $7.63 M(-14.4%) |
| Jun 2019 | - | $8.91 M(+50.9%) |
| Mar 2019 | - | $5.91 M(+0.6%) |
| Dec 2018 | $5.87 M(-0.6%) | $5.87 M(-14.0%) |
| Sep 2018 | - | $6.83 M(+60.9%) |
| Jun 2018 | - | $4.24 M(-28.2%) |
| Dec 2017 | $5.91 M(+165.3%) | $5.91 M |
| Dec 2016 | $2.23 M | - |
FAQ
- What is Y-mAbs Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual accounts payable year-on-year change?
- What is Y-mAbs Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly accounts payable year-on-year change?
What is Y-mAbs Therapeutics annual accounts payable?
The current annual accounts payable of YMAB is $6.06 M
What is the all time high annual accounts payable for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual accounts payable is $14.18 M
What is Y-mAbs Therapeutics annual accounts payable year-on-year change?
Over the past year, YMAB annual accounts payable has changed by -$8.12 M (-57.25%)
What is Y-mAbs Therapeutics quarterly accounts payable?
The current quarterly accounts payable of YMAB is $7.88 M
What is the all time high quarterly accounts payable for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly accounts payable is $14.66 M
What is Y-mAbs Therapeutics quarterly accounts payable year-on-year change?
Over the past year, YMAB quarterly accounts payable has changed by +$1.82 M (+30.00%)